Limitations to the use of bromelain-based enzymatic debridement (NexoBrid®) for treating diabetic foot burns: a case series of disappointing results.
Saved in:
| Title: | Limitations to the use of bromelain-based enzymatic debridement (NexoBrid®) for treating diabetic foot burns: a case series of disappointing results. |
|---|---|
| Authors: | Berner JE; Queen Victoria Hospital NHS Foundation Trust, East Grinstead, UK.; Kellogg College, University of Oxford, Oxford, UK., Keckes D; Queen Victoria Hospital NHS Foundation Trust, East Grinstead, UK., Pywell M; Queen Victoria Hospital NHS Foundation Trust, East Grinstead, UK., Dheansa B; Queen Victoria Hospital NHS Foundation Trust, East Grinstead, UK. |
| Source: | Scars, burns & healing [Scars Burn Heal] 2018 Dec 05; Vol. 4, pp. 2059513118816534. Date of Electronic Publication: 2018 Dec 05 (Print Publication: 2018). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: SAGE Publications Country of Publication: United States NLM ID: 101718377 Publication Model: eCollection Cited Medium: Internet ISSN: 2059-5131 (Electronic) Linking ISSN: 20595131 NLM ISO Abbreviation: Scars Burn Heal Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2059-5131 |
|---|---|
| DOI: | 10.1177/2059513118816534 |
